Voters Support Allowing Medicare to Negotiate Prescription Drug Pricing and the Clean Energy Performance Program
By Ethan Winter and Anika Dandekar
From September 24 to 27, 2021, Invest in America and Data for Progress conducted a survey of 1,292 likely voters nationally. We found that two progressive programs that have recently been threatened in Congress—allowing Medicare to negotiate prescription drug prices, and the Clean Energy Performance Program—are supported by large margins of likely voters.
A Bipartisan Majority of Voters Support Allowing Medicare to Negotiate Prescription Drug Prices
Among all likely voters, allowing Medicare to negotiate the cost of prescription drugs is backed by a +55-point margin of support, even when survey respondents are presented with the opposing view. Democrats, Independents, and Republicans all widely support the provision, with respective margins of +73, +50, and +39 points.
Voters Support the Clean Energy Performance Program
When shown arguments for and against the Clean Energy Performance Program, likely voters support the Clean Energy performance Program with a +25-point margin of support. Democrats and Independents support the program with respective margins of +67 and +19 points. In addition, 35 percent of Republicans support the program.
Toplines for this polling can be found here.
Ethan Winter (@EthanBWinter) is a senior analyst at Data for Progress. You can email him at ethan@dataforprogress.org.
Anika Dandekar is a polling analyst at Data for Progress.